Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 60,162 |
|
|||||
| News | (1) | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 3.00 | 2.36% | 130.0022 | 08:29:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 127.00 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1,102 | 60,162 | - | 99.14 - 133.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:29:26 | formt | 225 | $ 130.0022 | USD |
Merck (MRK) Options Flow Summary
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 321.65B | 2.53B | - | 60.12B | 365M | 0.14 | 881.33 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 125.52 | 128.10 | 124.50 | 126.38 | 7,605,379 | 4.48 | 3.57% |
| 1 Month | 132.23 | 132.42 | 124.50 | 127.44 | 6,717,652 | -2.23 | -1.68% |
| 3 Months | 123.44 | 133.10 | 119.41 | 125.61 | 8,291,177 | 6.56 | 5.32% |
| 6 Months | 103.45 | 133.10 | 99.80 | 116.34 | 8,358,948 | 26.55 | 25.67% |
| 1 Year | 116.215 | 133.10 | 99.14 | 113.05 | 7,702,645 | 13.79 | 11.86% |
| 3 Years | 78.00 | 133.10 | 70.89 | 93.36 | 9,974,956 | 52.00 | 66.67% |
| 5 Years | 74.55 | 133.10 | 65.25 | 88.28 | 9,975,276 | 55.45 | 74.38% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |
